Table 3.

Adverse events

	BMI <30 kg m−2			BMI ≥30 kg m−2			Safety cohorts
Group	SCB (n = 43)	ISB (n = 45)	Total (n = 88)	SCB (n = 10)	ISB (n = 9)	Total (n = 19)	SCB (n = 53)	ISB (n = 54)	Total (n = 107)
Patient with at least one AE	5 (12)	10 (22)	15 (17)	2 (20)	2 (22)	4 (21)	7 (13)	12 (22)	19 (18)
Patient with at least one mild AE	4 (9)	7 (16)	11 (13)	1 (10)	1 (11)	2 (11)	5 (9)	8 (15)	13 (12)
Patient with at least one moderate AE	1 (2)	2 (4)	3 (3)	1 (10)	1 (11)	2 (11)	2 (4)	3 (6)	5 (5)
Patient with at least one severe AE		1 (2)	1 (1)				–	1 (2)	1 (1)
Patient with at least one ongoing AE	2 (5)	2 (4)	4 (5)				2 (4)	2 (4)	4 (4)
Patient with at least one AE possibly related to treatment		4 (9)	4 (5)	1 (10)		1 (5)	1 (2)	4 (7)	5 (5)

Data are shown as n (%).

AE, adverse event; ISB, interscalene block; SCB, supraclavicular block.